Abstract-Computational
INTRODUCTION
Systems Biology is the amalgamation of computer science, mathematics, physics and biology. It endeavors to study, analyze and understand complex biological systems by taking a coordinated integrated systems view using computational methodologies (1) . Structure and dynamics of biological systems & prediction and inference in the complex systems is another significant implication (2) . The aim of modern systems biology is to elucidate physiology and disease from the level of molecular pathways, regulatory networks, cells, tissues, organs and ultimately the whole organism. As currently employed, the term 'systems biology' encompasses many different approaches and models for probing and understanding biological complexity, and studies of many organisms from bacteria to man (3) . Because biological complexity is an exponential function of the number of system components and the interactions between them, and escalates at each additional level of organization, efforts are currently limited to simple organisms or to specific minimal pathways (and generally in very specific cell and environmental contexts) in higher organisms (4) . Thus, methodologies that filter information for relevance, such as biological context and experimental knowledge of cellular and higher level system responses will be critical for successful understanding of different levels of organization in systems biology research (5) . Systems biology approaches can provide a solution to design lifesaving and cost-effective drugs so that the diseases can be cured and prevented. Systems based computational techniques will be highly useful in designing effective therapeutic drugs (6, 7) . System biology is defining biochemical networks in which biomolecules are showing the nodes and the molecular interactions between them are called the edges (8, 9) . Analytical methods such as gene expression clustering (13) , significance testing (14) (15) (16) (17) , and sequence motif identification (18) have been indispensable for enabling these discoveries and summarizing the data at each step.
II.
SYSTEM BIOLOGY PATHWAY MODELING Top-down modeling at the cell-to-organ and organism scale shows promise, but is extremely dependent on contextual cell response data. Moreover, to bridge the gap between omics and modeling, we need to collect a different type of cell biology data-data that incorporate the complexity and emergent properties of cell regulatory systems (10) (11) (12) (24) encompassing the disease responses, profiles made up of as few as 24-40 protein readouts (including cytokines, chemokines, adhesion receptors and other inflammatory mediators) used to assess the responses of these complex systems are able to discriminate and classify most of the pathways and mechanisms effected by known modulators of inflammation, as well as a surprising array of other drugs and pathways tested. Importantly, the profiles generated from these complex, activated cell mixtures are reproducible, allowing archiving in databases and automated searching and analyses by profile similarity or other characteristics (e.g., effects on key disease-relevant parameters) (25) . For target identification and validation, informatics approaches based on the similarity of database-stored multisystem profiles have been shown to rapidly associate gene or drug activities with known (or novel) pathways, and to predict functional pathways and network interactions (26) . Clustering multisystem response profiles, in which the systems are designed to capture emergent properties, can thus help define the functional architecture of signaling networks, information important (in conjunction with conventional data sets) for designing and testing computational models. Systematic two-hybrid screens and immunoprecipitation experiments are populating the public databases with thousands of protein-protein interactions and complexes (27, 28) . Other ongoing projects are defining large numbers of protein→DNA interactions (29) , and protein microarrays are making it possible to map interactions between proteins and drugs, hormones, and other small molecules (30) . These molecular interactions provide a paradigm for understanding changes in gene expression and for integrating a wide variety of global state measurements. One basis of systemic approaches to biological processes is the knowledge generated from genome sequencing and large-scale genetic analyses revealing an already enormous scale of interactions on the level of nucleic acids (31) (32) (33) . A general understanding of the topology of genetic-interaction networks in yeast has a wider importance, because similar networks are expected to underlie the relationship between genotype and phenotype in higher eukaryotic species (34).
III. SOFTWARE FOR USE IN SYSTEM BIOLOGY Cytoscape with its plug-ins:
Cytoscape is an open source bioinformatics software tool which is used for the visualizing molecular interaction networks and integrating it with gene expression. Cytoscape was developed at the Institute of System Biology in Seattle in 2002. It is written in java and used in any java-based operating systems. Cytoscape is a project dedicated to building open-source network visualization and analysis software. Software "Core" provides basic functionality to layout and query the network and to visually integrate the network with state data. The Core is extensible through a plug-in architecture, allowing rapid development of additional computational analyses and features (35, 36) . In present work we used the following four plug-ins-
BioNetBuilder:
BioNetBuilder is an open-source clientserver Cytoscape plug-in that offers a user-friendly interface to create biological networks integrated from several databases. Users can create networks for ~1500 organisms, including common model organisms and human. Currently supported databases include: DIP, BIND, Pro-links, KEGG, HPRD, The BioGrid, and GO, among others. The BioNetBuilder plug-in client is available as a Java Web start, providing a platform independent network interface to these public databases (37) . jActiveModulus: Identification of Modules of Seed and Neighboring Genes Using the jActiveModule Method (jAM).The MT method results in a large number of statistically significant predictions, but some of the predictions may be artifacts of low or excessive connectivity. To address this concern, the jActiveModule method is implemented to determine modules with maximal proportions of the lowest p value genes. jActiveModule Plug-in enumerates those ids which are actively participating in one or more function after the incorporation of compound in the microbe has already taken place. The jActiveModule plug-in gives those ids which are point of interest of our result these ids specifically are the once which depict to be actively taking post in the functioning of the microbes (38) . BiNGO: The Biological Networks Gene Ontology tool (BiNGO) is an open-source Java tool to determine which Gene Ontology (GO) terms are significantly overrepresented in a set of genes. BiNGO can be used either on a list of genes, pasted as text, or interactively on sub graphs of biological networks visualized in Cytoscape. BiNGO maps the predominant functional themes of the tested gene set on the GO hierarchy, and takes advantage of Cytoscape's versatile visualization environment to produce an intuitive and customizable visual representation of the 
IV. FUTURE PROSPECTS
Targets are prioritized because they are upregulated at the gene level in disease compounds are selected to be biochemically specific); animal models are considered essential. Markup languages for gene expression data, emerging ontologies for sharing and integrating different kinds of omics and conventional biological data and the introduction of standardized high-throughput systems biology and associated informatics approaches represent important first steps on this path. Computational biology and bioinformatics approaches have the potential to completely change the way drugs are discovered and designed. A shift from symptomatic oriented drugs that can relieve the symptoms but not the cause of the disease to pathology-based drugs whose targets are the genes and proteins involved in the etiology of the disease. Drugs targeting the affected pathway have thus the potential to become therapeutic. A network approach to drug design would examine the effect of drugs in the context of a network of relevant protein-protein, regulatory and metabolic interactions resulting in the development of a drug that would hit multiple targets selected in such a way as to decrease network integrity and so completely disrupt the functioning of the network. The screening of a compound to quickly identify the proteins it interacts with gives us all the necessary tools to identify and repair the unregulated biological pathway causing the disease.
V.
CONCLUSION The systems biology approaches outlined here are contributing to meaningful drug development decisions by accelerating hypothesis-driven biology. Modeling specific physiologic problems in target validation or clinical physiology and by providing rapid characterization and interpretation of disease-relevant cell and cell system level responses. An analogy can be drawn to the genome project, in which multiple individual efforts contributed technology and informatics approaches that eventually enabled a concerted 'big science' push to sequence the genome. The application of systems biology to medical practice is the future of medicine. Its realization will see drug discovery and the design of multiple drug therapies and therapeutic gene circuits being pursued just as occurs now with modern, complex engineering products. The daunting task ahead is to investigate our identified sub networks in the laboratory. Because large interaction networks are suspected to contain many false-positives, an initial experiment would be to verify that the interactions in each sub network are reproducible and present under the subnet's particular set of conditions. Routine network screening has to be performed to define novel modes of regulation, to identify evolutionarily conserved pathways, or to interrogate regulatory circuits responding to the entire spectrum of drugs and human diseases.
